Company Filing History:
Years Active: 1977-1983
Title: Mae Counelis: Innovator in Antibiotic Development
Introduction
Mae Counelis is a prominent inventor based in New York, NY (US). She has made significant contributions to the field of antibiotic research, holding a total of 3 patents. Her work focuses on the development of amino glycoside antibiotics, which have important applications in treating various infections.
Latest Patents
Among her latest patents, Mae Counelis has developed amino glycoside antibiotics that exhibit both antiprotozoal and anthelmintic properties. In the fermentation production of gentamicin C, a variety of additional antibiotic compounds are produced. Four of these compounds—gentamicin A, gentamicin B, gentamicin B.sub.1, and gentamicin X—demonstrate significant anti-protozoal and anthelmintic activity. Notably, gentamicin B and B.sub.1 also possess significant antibacterial properties while exhibiting markedly reduced side effects.
Career Highlights
Mae Counelis is associated with Schering Corporation, where she continues to advance her research in antibiotic development. Her innovative work has positioned her as a key figure in the pharmaceutical industry, contributing to the creation of safer and more effective antibiotic treatments.
Collaborations
Mae has collaborated with notable colleagues, including David J Cooper and Jay A Waitz. Their combined expertise has further enhanced the impact of her research in the field.
Conclusion
Mae Counelis is a trailblazer in the development of antibiotics, with a focus on improving treatment options for infections. Her contributions to the field are invaluable, and her ongoing work promises to lead to further advancements in antibiotic therapies.